150 related articles for article (PubMed ID: 2173175)
1. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
[TBL] [Abstract][Full Text] [Related]
2. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
7. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C prevalences among blood donors in the south region of Brazil.
Vasconcelos HC; Yoshida CF; Vanderborght BO; Schatzmayr HG
Mem Inst Oswaldo Cruz; 1994; 89(4):503-7. PubMed ID: 8524053
[TBL] [Abstract][Full Text] [Related]
9. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
Bettigole R; Shastri KA
J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
[TBL] [Abstract][Full Text] [Related]
12. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
[TBL] [Abstract][Full Text] [Related]
14. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
16. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
Janot C
Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
[No Abstract] [Full Text] [Related]
18. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
19. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
[TBL] [Abstract][Full Text] [Related]
20. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese.
Lin CK; Chu R; Li KB; Leong S
Vox Sang; 1992; 62(2):98-101. PubMed ID: 1325715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]